Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 38
Filter
1.
Clin Microbiol Infect ; 10(5): 448-51, 2004 May.
Article in English | MEDLINE | ID: mdl-15113324

ABSTRACT

Clinical isolates of methicillin-resistant Staphylococcus aureus (n = 1070) collected from 63 French general hospitals during June 2000 (n = 1070) were screened initially for reduced susceptibility to glycopeptides (GISA) on brain-heart infusion agar containing teicoplanin 6 mg/L. Glycopeptide MICs were determined for the 145 isolates that grew on the screening plates. Of the 1070 isolates, 1.4% were GISA on Mueller-Hinton agar, and 2.9% by Etest with a high inoculum, while 0.7% and 2.9% were GISA by vancomycin and teicoplanin population analysis profiles, respectively. Most isolates were resistant to gentamicin and rifampicin or fosfomycin or fusidic acid, as determined by disk diffusion. Pulsed-field gel electrophoresis of the 31 GISA isolates identified four clones, with dissemination of one predominant clone. In these French hospitals there was a low incidence of GISA and hetero-GISA.


Subject(s)
Anti-Bacterial Agents/pharmacology , Methicillin Resistance , Staphylococcal Infections/microbiology , Staphylococcus aureus/drug effects , Anti-Bacterial Agents/therapeutic use , Drug Resistance, Bacterial , Electrophoresis, Gel, Pulsed-Field , France/epidemiology , Humans , Microbial Sensitivity Tests , Staphylococcal Infections/drug therapy , Staphylococcal Infections/epidemiology , Staphylococcus aureus/isolation & purification , Teicoplanin/pharmacology , Teicoplanin/therapeutic use , Vancomycin/pharmacology , Vancomycin/therapeutic use , Vancomycin Resistance
2.
Clin Microbiol Infect ; 9(6): 560-2, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12848735

ABSTRACT

A newborn baby was admitted to the Neonatal Intensive Care Unit (NICU) of St Germain en Laye Hospital (France) because of premature birth. On day 12, he contracted gastroenteritis due to Salmonella brandenbourg. The salmonellosis led to a septic shock syndrome with a brief cardiopulmonary arrest. He was treated with intravenous ceftriaxone and gentamicin, and the evolution was favorable. Microbiological investigations revealed that the mother was the vector for this nosocomial infection. S. brandenbourg was isolated from the feces of the baby, despite recent recommendations on managing stool specimens from patients hospitalized for more than three days: according to these recommendations, these stools should be processed for viruses and Clostridium difficile toxin only.


Subject(s)
Cross Infection/transmission , Salmonella Infections/transmission , Salmonella/physiology , Visitors to Patients , Female , Humans , Infant, Newborn , Intensive Care Units, Neonatal , Male , Shock, Septic/physiopathology , Shock, Septic/transmission
3.
J Hosp Infect ; 52(2): 107-13, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12398076

ABSTRACT

In order to measure the incidence of methicillin-resistant Staphylococcus aureus (MRSA) and of Enterobacteriaceae producing extended-spectrum beta-lactamase (ESBLE), and to evaluate the impact of the national guidelines for multidrug-resistant bacteria (MDRB) prevention in hospitals of Northern France, a multicentre study was conducted for three months every year starting in 1996, in volunteer hospital laboratories. All clinical specimens positive for MRSA and ESBLE were prospectively surveyed. During the five-year surveillance period, the overall proportion of MRSA was 38.4% in the 28,534 strains of S. aureus, and that of ESBLE was 11.4% in the 6121 strains of Klebsiella pneumoniae and 47.7% in the 2353 strains of Enterobacter aerogenes. The overall incidence rates of clinical specimens positive for MRSA, ESBL-K. pneumoniae and E. aerogenes were 0.84. 0.05 and 0.12/1000 hospital-days (HD), respectively. In the 23 hospitals that participated in the survey every year, the proportion and incidence of ESBLE decreased. Hence, despite recommendations as for isolation precautions, MRSA remains poorly controlled and requires more effective measures.


Subject(s)
Bacteremia/epidemiology , Cross Infection/epidemiology , Klebsiella Infections/epidemiology , Klebsiella pneumoniae/isolation & purification , Population Surveillance , Staphylococcal Infections/epidemiology , Staphylococcus aureus/drug effects , beta-Lactamases/metabolism , Anti-Bacterial Agents/therapeutic use , Bacteremia/drug therapy , Cross Infection/drug therapy , Enterobacteriaceae , France/epidemiology , Humans , Incidence , Klebsiella Infections/drug therapy , Methicillin Resistance , Staphylococcal Infections/drug therapy , Staphylococcus aureus/isolation & purification
4.
Rev Med Interne ; 22(1): 75-8, 2001 Jan.
Article in French | MEDLINE | ID: mdl-11218303

ABSTRACT

INTRODUCTION: Primary meningococcal arthritis is a rare form of meningococcal disease. It occurs as an isolated acute purulent arthritis without meningitis, and presence of Neisseria meningitidis in articular fluid. We report a new case of typical primary meningococcal arthritis. EXEGESIS: A previously healthy 23-year-old female patient was admitted for purpuric lesions of the legs. At admission, conscience was normal and symptoms of meningitis were absent. During the 2nd day of hospitalisation, a warm and painful effusion in the right knee appeared. Aspiration from the right knee yielded a purulent fluid. N. meningitidis was isolated from a blood-culture vial inoculated with the synovial fluid, while blood cultures remained sterile. Anti-biotherapy was initiated as soon as microbiological diagnosis was established. The patient was symptom-free 1 month later. CONCLUSION: We emphasize the fact that agar cultures of the synovial fluid remained sterile, while N. meningitidis grew in a blood-culture vial. We suggest that diagnosis of primary meningococcal arthritis may be underestimated when inappropriate culture media are used.


Subject(s)
Arthritis, Infectious/pathology , Knee Joint/microbiology , Meningococcal Infections/pathology , Neisseria meningitidis/isolation & purification , Adult , Arthritis, Infectious/diagnosis , Blood Specimen Collection , Colony Count, Microbial , Female , Humans , Meningococcal Infections/diagnosis , Synovial Fluid/microbiology
6.
Pathol Biol (Paris) ; 44(5): 411-5, 1996 May.
Article in French | MEDLINE | ID: mdl-8758486

ABSTRACT

During 2 months (01.01.95-28.02.95), we noted for each Staphylococcus aureus (SA) isolates, identification and susceptibility methods, hospital size, medical speciality, source, penicillin (P) and methicillin (M) susceptibility. For each non repetitive methicillin resistant SA we noted phenotype of aminoglycoside resistance of SA to 6 antistaphylococci drugs. We isolated 399 SA, SAP sensitives 6.5%, methicillin resistant SA (MRSA) 31.8%. MRSA in acute care unit 28.4%, non acute care unit 61.7%, surgery 28.6%, medicine 36.5%, orthopedics 34.5%, pédiatrics 4%, ICU 38.8%, others 10.3%. MRSA from wound 28.2%, respiratory tract 38.3% blood 22.5%, urine 58.5%, others 25.8% - MRSA kanamycin 1.7%, kanamycin tobramycin 36.2%, kanamycin, tobramycin, gentamicin 56.9% - MRSA erythromycin 79.5%, pefloxacin 91.3%, rifampicin 53.5%, acide fusidique 8.7%, fosfomycine 18.9%, TMP SMZ 5.5%. The proportion MRSA is equivalent among medical specialities predominant in urine cultures and respiratory tract. It should be better to carry on the survey for more than two months in each hospital.


Subject(s)
Anti-Bacterial Agents/pharmacology , Methicillin/pharmacology , Penicillins/pharmacology , Staphylococcal Infections/epidemiology , Staphylococcus aureus/drug effects , Aminoglycosides , France/epidemiology , Hospital Units , Humans , In Vitro Techniques , Length of Stay , Methicillin Resistance , Prevalence , Prospective Studies , Staphylococcal Infections/microbiology , Staphylococcus aureus/isolation & purification
7.
J Antimicrob Chemother ; 36(3): 527-30, 1995 Sep.
Article in English | MEDLINE | ID: mdl-8830017

ABSTRACT

In-vitro activity of CI-960 against seven strains of Listeria monocytogenes was compared to that of other fluoroquinolones. MICs/MBCs were: ciprofloxacin and sparfloxacin: 0.5-2/1-4 mg/L;PD 131628: 0.125-0.5/0.25-2 mg/L; CI-960: 0.06-0.25/0.25-0.5 mg/L. At 4 h, CI-960 (4 x MIC) reduced the inoculum (log10 cfu) by 2.88 +/- 0.61 compared with 1.78 +/- 0.48 for ciprofloxacin, 1.5 +/- 0.46 for sparfloxacin, and 1.35 +/- 0.47 for PD 131628 (P < 0.05). At 24 h, the bactericidal effects were similar (-4 log10 cfu). The amoxycillin/CI-960 (8 x MIC) combination was bactericidal, without emergence of resistant mutants.


Subject(s)
Amoxicillin/pharmacology , Anti-Infective Agents/pharmacology , Fluoroquinolones , Listeria monocytogenes/drug effects , Penicillins/pharmacology , Quinolones/pharmacology , Drug Combinations , Microbial Sensitivity Tests
8.
J Clin Microbiol ; 32(3): 701-4, 1994 Mar.
Article in English | MEDLINE | ID: mdl-8195382

ABSTRACT

Two cases of laboratory-acquired infections due to Neisseria meningitidis were suspected to have occurred in two French hospitals. The first case occurred shortly, i.e., 3 days, after one strain had been handled by a laboratory technician, and the link between this strain and the strain causing meningitis was easily established. In the second case, infection occurred 3 weeks after 10 strains had been handled by a technician. In this case, it was necessary to use high-resolution markers in order to establish the link between the infecting strain and 1 of the 10 strains handled. The antigenic formulae of the two infecting strains (serogroup:serotype:subtype) were, respectively, C:NT:P1.12 and B:2a:P1.2. Outer membrane protein profile analysis and multilocus enzyme electrophoresis unequivocally confirmed the identity of the respective strains.


Subject(s)
Laboratory Infection/microbiology , Meningitis, Meningococcal/microbiology , Neisseria meningitidis/enzymology , Adult , Antigens, Bacterial , Bacterial Outer Membrane Proteins/isolation & purification , Enzymes/genetics , Enzymes/isolation & purification , France , Genotype , Humans , Neisseria meningitidis/chemistry , Neisseria meningitidis/classification , Serotyping
10.
Ann Pediatr (Paris) ; 38(9): 637-41, 1991 Nov.
Article in French | MEDLINE | ID: mdl-1750748

ABSTRACT

This study carried out at the Saint-Germain-en-Laye Hospital maternity ward included all the neonates delivered between February and September 1989 who exhibited no abnormal manifestations during their stay in the ward, except for ocular symptoms in some subjects. Nine hundred neonates were enrolled. Each day, one of two eyedrop preparations for the prevention of neonatal ocular infections was selected at random. Investigators were blinded to the preparation used. Study subjects were evaluated twice, between D1 and D7 (900 infants) and between D15 and D30 (407 infants). Ocular findings were classified as follows: normal, minimally abnormal (isolated swelling of the eyelids, clear discharge), or frankly abnormal (conjunctivitis, purulent discharge). A bacteriologic study was performed in all patients with minimally abnormal or abnormal findings. Between D1 and D7, ocular symptoms were significantly (p less than 0.05) more prevalent in neonates treated with silver nitrate than in neonates treated with oxytetracycline hydrochloride. This difference was no longer present between D15 and D30. Bacteriologic studies recovered no gonococci. One enfant in the oxytetracycline group had bacteriologically confirmed Chlamydia trachomatis ocular infection. The other organisms recovered were mainly Staphylococcus aureus and non-hemolytic streptococci. In inclusion, no currently available eyedrop preparation offers complete protection against C. trachomatis but tolerance is considerably better with oxytetracycline hydrochlorate than with silver nitrate.


Subject(s)
Conjunctivitis, Bacterial/prevention & control , Ophthalmic Solutions/therapeutic use , Oxytetracycline/therapeutic use , Silver Nitrate/therapeutic use , Female , Humans , Infant, Newborn , Male , Oxytetracycline/administration & dosage , Silver Nitrate/administration & dosage , Staphylococcal Infections/prevention & control , Streptococcal Infections/prevention & control , Time Factors
12.
Pathol Biol (Paris) ; 39(5): 486-8, 1991 May.
Article in French | MEDLINE | ID: mdl-1881679

ABSTRACT

Susceptibility to beta-lactam antibiotics of strains of Enterobacteriaceae consecutively isolated in nine general hospitals during a period of 2 months (march and april) has been studied by the disk-agar diffusion method. The separation between susceptible and resistant strains was based on the measure of the inhibition zones centered by 2 disks: cephalothin and ticarcillin. Enterobacteriaceae were divided in 2 groups: strains isolated during the first 48 h of hospitalisation or isolated after. Fifty one per cent of the strains were isolated during the first 48 h: they did not belong to the residential flora of these hospitals. Klebsiella, Proteus indole positive, Providencia, Enterobacter, Serratia were more frequently isolated after 48 h of hospitalisation. Susceptible strains of Klebsiella, Proteus indole positive, Providencia, Serratia were more rarely isolated after 48 h of hospitalisation. E. coli whatever the duration of hospitalisation, is the less frequent susceptible bacterium.


Subject(s)
Cephalothin/pharmacology , Enterobacteriaceae Infections/microbiology , Enterobacteriaceae/drug effects , Ticarcillin/pharmacology , Drug Resistance, Microbial , Enterobacteriaceae/isolation & purification , France , Humans , In Vitro Techniques , Length of Stay
14.
J Clin Microbiol ; 28(11): 2520-5, 1990 Nov.
Article in English | MEDLINE | ID: mdl-2254429

ABSTRACT

To determine the incidence rate of complications associated with vascular catheters in intensive care unit patients and to analyze risk factors for a positive vascular culture, we performed a multicenter study of intensive care unit patients at eight French hospitals. During the study period, 865 intravenous catheters were inserted in 566 patients; 362 (41.8%) were peripheral catheters, and 503 (58.2%) were central catheters. Local complications (i.e., infiltration) occurred significantly more often with peripheral than with central catheters (P less than 0.001); in contrast, fever and bacteremia were significantly more often associated with central than with peripheral catheters (P less than 0.01 and P less than 0.05, respectively). The culture of the vascular-catheter tip was positive for 24% of central catheters (32 of 1,000 catheters days) and for 9% of peripheral catheters (21 of 1,000 catheters days). Staphylococcus epidermidis was the most common microorganism isolated from both peripheral and central catheters, followed by Staphylococcus aureus and Pseudomonas aeruginosa. No significant risk factor associated with positive cultures for peripheral catheters was found by univariate analysis. In contrast, the purpose of the cannula (nutrition and monitoring of central venous pressure), the insertion site (jugular), the dressing type (semipermeable transparent dressing), the antiseptic used to prepare the insertion site (povidone iodine), and routine changing of the intravenous administration set were significantly associated with positive cultures of central catheters. Three factors, duration of catheterization, use of a semipermeable transparent dressing, and the jugular insertion site, were found to be independently associated with positive cultures of central catheters by multivariate analysis.


Subject(s)
Catheterization/adverse effects , Sepsis/etiology , Catheterization, Central Venous/adverse effects , Catheterization, Peripheral/adverse effects , Humans , Intensive Care Units , Prospective Studies , Risk Factors
16.
Antimicrob Agents Chemother ; 34(9): 1695-8, 1990 Sep.
Article in English | MEDLINE | ID: mdl-2126687

ABSTRACT

A mutant with decreased susceptibility to imipenem (IpR) was selected in vitro from a susceptible clinical isolate of Listeria monocytogenes (IpS). IpR exhibited decreased susceptibility to penicillin G (4 x MIC) and imipenem (16 x MIC) and increased susceptibility to cefotaxime (0.25 x MIC). Electrophoretic profiles of membrane proteins and penicillin-binding proteins (PBPs) were identical in the two strains; each strain had five PBPs with molecular masses of ca. 97, 83.3, 81, 77.1, and 42.6 kilodaltons. A decreased affinity of PBP 3 for penicillin G and imipenem (10-fold) was observed in IpR. In contrast, the affinity of PBP 3 for cefotaxime in IpR was increased twofold and correlated with the decreased MIC of this drug. From these findings and competition experiments with different beta-lactam antibiotics, we conclude that the alteration of PBP 3 is responsible for the decreased susceptibility of IpR to penicillin and imipenem and that PBP 3 might be an essential target of beta-lactam antibiotics in L. monocytogenes.


Subject(s)
Carrier Proteins/metabolism , Hexosyltransferases , Imipenem/pharmacology , Listeria monocytogenes/metabolism , Muramoylpentapeptide Carboxypeptidase/metabolism , Peptidyl Transferases , Anti-Bacterial Agents/metabolism , Bacterial Proteins/metabolism , Cefotaxime/metabolism , Cephalothin/metabolism , Drug Resistance, Microbial/physiology , Electrophoresis , Imipenem/metabolism , Listeria monocytogenes/genetics , Membrane Proteins/metabolism , Microbial Sensitivity Tests , Mutation , Penicillin G/metabolism , Penicillin-Binding Proteins
17.
Eur J Clin Microbiol Infect Dis ; 9(3): 206-9, 1990 Mar.
Article in English | MEDLINE | ID: mdl-2110900

ABSTRACT

The in vitro bactericidal activity of amoxicillin, gentamicin, rifampicin, ciprofloxacin and trimethoprim-sulfamethoxazole alone or in combination was determined against seven strains of Listeria monocytogenes by the killing curve method. Amoxicillin plus gentamicin was the most rapidly bactericidal combination, whereas trimethoprim-sulfamethoxazole was less bactericidal at 6 h but as bactericidal at 24 h. The combination of trimethoprim-sulfamethoxazole with either amoxicillin, ciprofloxacin or rifampicin did not result in antagonism, but the combinations were no more active than trimethoprim-sulfamethoxazole alone. The interaction of amoxicillin with rifampin was fairly antagonistic (1 log10 difference). The combination of amoxicillin and ciprofloxacin, although producing antagonism during the first 6 h, was more active at 24 h than amoxicillin alone and prevented the regrowth observed with ciprofloxacin alone. Ciprofloxacin and rifampicin interacted antagonistically during the first 6 h, and the combination was not very bactericidal (3 log10) but prevented the emergence of mutants, as observed with each drug alone, when used at concentrations greater than the MICs for the strain tested. These regimens merit evaluation in in vivo models of Listeria monocytogenes meningitis.


Subject(s)
Anti-Bacterial Agents/pharmacology , Listeria monocytogenes/drug effects , Drug Therapy, Combination/pharmacology , Humans , In Vitro Techniques , Listeria monocytogenes/isolation & purification , Listeriosis/drug therapy , Listeriosis/microbiology , Meningitis, Listeria/drug therapy , Microbial Sensitivity Tests
19.
J Antimicrob Chemother ; 23(4): 503-8, 1989 Apr.
Article in English | MEDLINE | ID: mdl-2501270

ABSTRACT

Enterococcus faecium D399 was isolated from the blood and peritoneal abscess of a patient with intraabdominal sepsis. The patient had not been treated with vancomycin, but the strain was found to be resistant with a MIC of 1000 mg/l. Resistance was inducible and transferable (probably by conjugation) to JH2-2, and correlated with induction of synthesis of a 39 kDa protein. This mechanism appears to be identical to that previously described for E. faecalis A256, suggesting that dissemination of this form of glycopeptide resistance has already occurred. The resistance phenotype of D399, however, differed somewhat from that found in other enterococcal strains with inducible resistance.


Subject(s)
Enterococcus faecalis/drug effects , Vancomycin/pharmacology , Drug Resistance, Microbial , Electrophoresis, Polyacrylamide Gel , Glycopeptides/pharmacology , Microbial Sensitivity Tests , Time Factors
20.
J Antimicrob Chemother ; 22(5): 651-7, 1988 Nov.
Article in English | MEDLINE | ID: mdl-3145267

ABSTRACT

Pseudomonas aeruginosa mutants were selected with piperacillin, pefloxacin, amikacin and the combinations pefloxacin-piperacillin and amikacin-piperacillin. With amikacin and the piperacillin-amikacin combination no mutants were selected. With piperacillin (1-32 x MIC) mutants resistant to carboxypenicillins, ureidopenicillins, monobactam and cephalosporins were selected. With pefloxacin, three different types of mutant were observed which showed different patterns of cross-resistance to pefloxacin, sulphonamides, imipenem, piperacillin and other beta-lactam antibiotics. With the pefloxacin-piperacillin association, mutants similar to one of the types selected by pefloxacin alone and resistant to both of the selective antibiotic were predominantly obtained. No mutants were selected with this combination if one of the antibiotics was used at a concentration equal to its MIC for the wild type strain and the other at concentrations above 4 x MIC. Since the association of piperacillin and pefloxacin was only moderately bactericidal against the predominantly cross-resistant mutant selected, the concentration of these antibiotics may have to be carefully controlled to prevent the emergence of such mutants.


Subject(s)
Amikacin/pharmacology , Mutation , Pefloxacin/pharmacology , Piperacillin/pharmacology , Pseudomonas aeruginosa/drug effects , Drug Interactions , Microbial Sensitivity Tests , Phenotype , Pseudomonas aeruginosa/genetics , Selection, Genetic , beta-Lactamases/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...